Endoc Biotech is an innovation-driven biopharmaceutical company, specializing in the Fermenter-based manufacturing of Active Pharmaceutical Ingredients (APIs). Established in 2020 in Rajkot, Endoc operates a world-class pharmaceutical manufacturing facility that adheres to rigorous regulatory standards, including FDA, WHO, and EU compliance. By following cGMP and regulatory guidelines, Endoc Biotech ensures the production of high-quality drug molecules.
Endoc has quickly emerged as a leading manufacturer of Mupirocin in the pharmaceutical market, gaining recognition for excellence and reliability.
With state-of-the-art manufacturing facilities and a team of seasoned professionals, Endoc Biotech excels in bulk drug and intermediate manufacturing. Our robust infrastructure, including cutting-edge research and development labs, plant equipment, and a dedicated workforce, is located in Rajkot—one of India’s premier industrial hubs. We are committed to providing reliable services to clients worldwide, backed by our expertise and unwavering commitment to quality.
To emerge as a world-class pharmaceutical company that positively impacts lives across the globe, while achieving sustainable growth and emerging as a market leader in the pharmaceutical industry
To enrich lives globally by leading the development of innovative biotechnology-driven products that meet critical human needs
Endoc takes a research intensive and data- driven approach to identify the best possible molecular development structures for creating API solutions that are cost-effective. We employ high-performing equipment and human force to develop APIs that would cater to different therapeutic areas, whilst constantly evolving to bring more drug solutions in the medical society.